Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-19

Clinical Trial Update: External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating external beam radiation therapy in combination with talquetamab for the treatment of multiple myeloma with extramedulla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Talquetamab (talquetamab)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Extramedullary Disease in Multiple Myeloma, Multiple Myeloma | Phase 1, Phase 2 | Status: RECRUITING